A Spanish study found that nirsevimab prophylaxis significantly reduced infant hospitalizations, ICU admissions, and severe ...

It is also developing its own therapies for respiratory syncytial virus (RSV), human metapneumovirus (hMPV) and chronic hepatitis B virus (HBV), and started work on COVID-19 early in in the ...

Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being dangerous to babies and toddlers due to how often child-related ...

Get Respiratory Viruses latest news, Article video and Photos on Respiratory Viruses Explore latest health updates, news, information from TheHealthSite.com ...

But what is not brought up is the very high likelihood that your healthy baby may be hospitalized if exposed to respiratory syncytial virus, better known as RSV. According to the CDC, RSV is the ...

Meanwhile the flu, RSV and HMPV infections, which all slightly vary in symptoms, and could benefit from different treatment methods, are also common during this time of the year. Strep A and ...

"Last year, we noted a significant increase in hospital admissions for respiratory conditions. These included flu, pneumonia, H1N1, RSV, HMPV and COVID-19", says Lee Callakoppen, Principal Officer of ...

In addition, we will present 20 years of effectiveness data for Fluenz/FluMist, as well as real-world data highlighting the ongoing burden of RSV and hMPV, two leading causes of respiratory illnesses.